Cardiovascular outcomes data for Ozempic comes from the SELECT trial, which demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with established heart disease but without diabetes
The LEADER trial with liraglutide, SUSTAIN-6 with once-weekly semaglutide, and REWIND with dulaglutide each showed robust cardioprotective signals and favorable renal outcomes [8,9,10]
When should I contact my GP about leg cramps on GLP-1 medication
Grains, Starches, and Added Sugars All grains, starches, and added sugars are excluded from the grapefruit diet, making it very restrictive